Undergraduate School

B.S., National Chung Hsing University, Taiwan 2001

Medical School

M.D., University of Miami Miller School of Medicine, Miami FL 2006

Other School

Ph.D., UC Davis, Davis 2017

Residency

Anesthesiology, UC Davis, Davis CA 2017-2022

Park JY, Lin PY, Weiss RH. Targeting the PI3K-Akt pathway in kidney cancer. Expert Rev Anticancer Ther. 2007 Jun;7(6):863-70. doi:10.1586/14737140.7.6.863. PMID:17555396.

Lin PY, Fosmire SP, Park SH, Park JY, Baksh S, Modiano JF, Weiss RH. Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance. Mol Cancer. 2007 Feb 14;6:16. doi:10.1186/1476-4598-6-16. PMID:17300726.

Weiss RH, Borowsky AD, Seligson D, Lin PY, Dillard-Telm L, Belldegrun AS, Figlin RA, Pantuck AD. p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches. J Urol. 2007 Jan;177(1):63-8; discussion 68-9. doi:10.1016/j.juro.2006.08.073. PMID:17162001.

Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, Kültz D, Weiss RH. Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol Cancer. 2006 Nov 24;5:64. doi:10.1186/1476-4598-5-64. PMID:17123452.

Weiss RH, Lin PY. Kidney cancer: identification of novel targets for therapy. Kidney Int. 2006 Jan;69(2):224-32. doi:10.1038/sj.ki.5000065. PMID:16408110.